Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSX/BHC stock hub

TSX/BHC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/BHCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.9B

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/BHC

In the news

Latest news · TSX/BHC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E1.3

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROIC12.5

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/BHC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	20,300
Employees Change	430%
Employees Change Percent	2.12
Enterprise value	CAD 31B
Exchange	Toronto Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA0717341071
Last refreshed	2026-05-10
Market cap	CAD 2.9B
Price	CAD 7.88
Price currency	CAD
Rev Per Employee	724,128.16x
Sector	Healthcare
Sic	2834
Symbol	tsx/BHC
Website	https://www.bauschhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-57.36%
EV Earnings	-18.36x
EV/EBIT	9.36x
EV/EBITDA	6.08x
EV/FCF	21.58x
EV/Sales	2.15x
FCF yield	48.81%
Forward P/E	1.34x
P/B ratio	-1.95x
P/S ratio	0.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.94%
EBITDA Margin	34.32%
FCF margin	9.76%
Gross margin	71.04%
Gross Profit	CAD 10.4B
Gross Profit Growth	8.61%
Gross Profit Growth Q	14.63%
Gross Profit Growth3 Y	9.14%
Gross Profit Growth5 Y	5.45%
Net Income	CAD -1.7B
Net Income Growth Years	2%
Pretax Margin	-8.93%
Profit Margin	-11.47%
Profit Per Employee	CAD -83,064
Profitable Years	1
ROA	5.93
Roa5y	4.05
ROCE	12.1
ROIC	12.53
Roic5y	4.32

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-14.69%
Cagr15y	-11.43%
Cagr1y	21.06%
Cagr20y	-4.68%
Cagr3y	0.43%
Cagr5y	-25.39%
EPS Growth Years	2
FCF Growth	-16.22%
FCF Growth Q	26.04%
FCF Growth5 Y	0.61%
OCF Growth	-11.15%
OCF Growth Q	9.01%
OCF Growth10 Y	-4.81%
OCF Growth5 Y	1.88%
Revenue Growth	8.22x
Revenue Growth Q	11.73x
Revenue Growth Quarters	2x
Revenue Growth Years	3x
Revenue Growth3 Y	8.92x
Revenue Growth5 Y	5.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.41
Assets	CAD 34.2B
Cash	CAD 1.8B
Current Assets	CAD 8.2B
Current Liabilities	CAD 6.2B
Debt	CAD 29B
Debt EBITDA	CAD 5.59
Debt FCF	CAD 20.23
Equity	CAD -1.5B
Interest Coverage	1.44
Liabilities	CAD 35.7B
Long Term Assets	CAD 26B
Long Term Liabilities	CAD 29.5B
Net Cash	CAD -27.2B
Net Cash By Market Cap	CAD -926
Net Debt EBITDA	CAD 5.39
Net Debt FCF	CAD 18.96
Tangible Book Value	CAD -22.7B
Tangible Book Value Per Share	CAD -60.81
WACC	6.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.32
Inventory Turnover	1.9
Net Working Capital	CAD 1.5B
Quick ratio	0.77
Working Capital	CAD 2B
Working Capital Turnover	CAD 10.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.81%
Dividend per share	CAD 0
Last Dividend	CAD 1

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-79.57%
1Y total return	21.05%
200-day SMA	8.79
3Y total return	1.29%
50-day SMA	7.5
50-day SMA vs 200-day SMA	50under200
5Y total return	-76.88%
All Time High	347.8
All Time High Change	-97.73%
All Time High Date	2015-08-06
All Time Low	0.46
All Time Low Change	1,619.4%
All Time Low Date	1994-04-19
ATR	0.31
Beta	0.42
Ch YTD	-17.31
High	7.93
High52	11.97
High52 Date	2025-08-15
High52ch	-34.17%
Low	7.73
Low52	6.06
Low52 Date	2025-06-02
Low52ch	30.03%
Ma50ch	5.02%
Price vs 200-day SMA	-10.3%
RSI	56.12
RSI Monthly	43.6
RSI Weekly	46.79
Sharpe ratio	0.55x
Sortino ratio	1.03
Total Return	-0.81%
Tr YTD	-17.31
Tr15y	-83.81%
Tr1m	7.8%
Tr1w	2.74%
Tr3m	-1.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 3.4B
Operating Income Growth	29.06
Operating Income Growth Q	75.42
Operating Income Growth3 Y	20.55
Operating Income Growth5 Y	11.04
Operating margin	22.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	260,570,783%
Net Borrowing	-784,686,700
Shares Insiders	10.6%
Shares Institutions	34.59%
Shares Qo Q	-0.14%
Shares Yo Y	0.81%
Short Float	0.92%
Short Ratio	3.2
Short Shares	0.78

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 1.1B
Average Volume	367,870.2x
Bv Per Share	-7.7
CAPEX	CAD -545.8M
Ch10y	-79.57
Ch15y	-83.81
Ch1m	7.8
Ch1w	2.74
Ch1y	21.05
Ch20y	-72.72
Ch3m	-1.87
Ch3y	1.29
Ch5y	-76.88
Ch6m	-15.54
Change	0.77%
Change From Open	0.64
Close	7.82
Days Gap	0.13
Depreciation Amortization	1,637,725,900
Dollar Volume	1,984,625.3
Earnings Date	2026-04-29
EBIT	CAD 3.4B
EBITDA	CAD 5B
EPS	CAD -4.54
F Score	6
FCF	CAD 1.4B
FCF EV Yield	4.63x
Financing CF	-971,518,560
Fiscal Year End	December
Goodwill	13,406,659,350
Income Tax	CAD 397.8M
Investing CF	-843,099,440
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2000-10-05
Last Split Type	Forward
Ma150	8.53
Ma150ch	-7.59%
Ma20	7.79
Ma20ch	1.14%
Net CF	216,358,300
Next Earnings Date	2026-07-30
Open	7.83
P FCF Ratio	2.05
P OCF Ratio	1.48
Position In Range	75
Ppne	2,863,969,750
Price Date	2026-05-08
Price EBITDA	CAD 0.58
Relative Volume	0.71x
Revenue	14,699,801,660x
SBC By Revenue	2.14x
Share Based Comp	314,068,500
Tax By Revenue	2.71x
Tr20y	-61.64%
Tr6m	-15.54%
Volume	251,856
Z Score	0.25

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSX/BHC pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/BHC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/BHC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+34.6%

Share of float held by funds and institutions

Insider ownership

+10.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TSX/BHC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.1

Neutral momentum band

Price vs 200-day MA

-10.3%

50/200-day relationship not available

Beta (5Y)

0.42

Less volatile than the market

Sharpe ratio

0.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/BHC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/BHC stock rating?

tsx/BHC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/BHC analysis?

The full report lives at /stocks/tsx/BHC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/BHC?

The latest report frames tsx/BHC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/BHC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.